SG11202107531PA - Method for preparation of 1,4-sorbitan in aqueous medium - Google Patents
Method for preparation of 1,4-sorbitan in aqueous mediumInfo
- Publication number
- SG11202107531PA SG11202107531PA SG11202107531PA SG11202107531PA SG11202107531PA SG 11202107531P A SG11202107531P A SG 11202107531PA SG 11202107531P A SG11202107531P A SG 11202107531PA SG 11202107531P A SG11202107531P A SG 11202107531PA SG 11202107531P A SG11202107531P A SG 11202107531PA
- Authority
- SG
- Singapore
- Prior art keywords
- sorbitan
- preparation
- aqueous medium
- aqueous
- medium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/20—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2019071900 | 2019-01-16 | ||
| US201962799821P | 2019-02-01 | 2019-02-01 | |
| EP19154950 | 2019-02-01 | ||
| EP19157027 | 2019-02-13 | ||
| EP19157025 | 2019-02-13 | ||
| PCT/EP2020/051059 WO2020148404A1 (en) | 2019-01-16 | 2020-01-16 | Method for preparation of 1,4-sorbitan in aqueous medium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202107531PA true SG11202107531PA (en) | 2021-08-30 |
Family
ID=69190760
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202107531PA SG11202107531PA (en) | 2019-01-16 | 2020-01-16 | Method for preparation of 1,4-sorbitan in aqueous medium |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220064135A1 (de) |
| EP (1) | EP3911635A1 (de) |
| JP (1) | JP2022518029A (de) |
| KR (1) | KR20210135995A (de) |
| CN (1) | CN113330002A (de) |
| CA (1) | CA3126742A1 (de) |
| SG (1) | SG11202107531PA (de) |
| WO (1) | WO2020148404A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11174236B2 (en) * | 2018-08-27 | 2021-11-16 | Lonza Guangzhou Pharmaceutical Ltd. | Method for preparation of 1,4-sorbitan |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101948451B (zh) | 2010-08-18 | 2013-03-06 | 南京威尔化工有限公司 | 高纯度1,4-失水山梨醇的制备方法 |
| CN106167476B (zh) * | 2016-07-20 | 2018-01-12 | 广州嘉德乐生化科技有限公司 | 一种油酸山梨坦的制备方法 |
-
2020
- 2020-01-16 CN CN202080010466.3A patent/CN113330002A/zh active Pending
- 2020-01-16 KR KR1020217024083A patent/KR20210135995A/ko active Search and Examination
- 2020-01-16 CA CA3126742A patent/CA3126742A1/en active Pending
- 2020-01-16 WO PCT/EP2020/051059 patent/WO2020148404A1/en unknown
- 2020-01-16 EP EP20701705.4A patent/EP3911635A1/de not_active Withdrawn
- 2020-01-16 US US17/423,193 patent/US20220064135A1/en not_active Abandoned
- 2020-01-16 JP JP2021541299A patent/JP2022518029A/ja active Pending
- 2020-01-16 SG SG11202107531PA patent/SG11202107531PA/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3911635A1 (de) | 2021-11-24 |
| KR20210135995A (ko) | 2021-11-16 |
| US20220064135A1 (en) | 2022-03-03 |
| WO2020148404A1 (en) | 2020-07-23 |
| JP2022518029A (ja) | 2022-03-11 |
| CA3126742A1 (en) | 2020-07-23 |
| CN113330002A (zh) | 2021-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2018001491A (es) | Metodos para la preparacion de acidos biliares y derivados de los mismos. | |
| IL286471B1 (en) | The history of phenylisoxazolidine (pyridine-amino-phenyl)-acrylamide, a method for their preparation and a pharmaceutical preparation containing them | |
| EP3730623A4 (de) | Kleinmolekulare hyaluronsäure oder deren salze und verfahren zu ihrer herstellung | |
| EP3752149A4 (de) | Chinolonanaloga und deren salze, zusammensetzungen und verfahren zu deren verwendung | |
| EP3502103A4 (de) | Kristallform, salztyp von substituiertem 2-hydro-pyrazol-derivat und herstellungsverfahren dafür | |
| EP3564218A4 (de) | Verfahren zur herstellung von 1,4,7,10-tetraazacyclododecan-1,4,7,10-tetraessigsäure | |
| IL276244A (en) | A pharmaceutical preparation for the eyes, a method for its preparation and its application | |
| EP3786179A4 (de) | Extrazelluläre matrix enthaltende zusammensetzung, verfahren zu ihrer herstellung, dreidimensionales gewebekonstrukt und mittel zur bildung eines dreidimensionalen gewebekonstrukts | |
| IL276430A (en) | A pharmaceutical compound, its cures, its formulations, and methods for its preparation and use | |
| EP3530650A4 (de) | Kristalline form von (r)-4-hydroxy-2-oxo-1-pyrrolidinacetamid, herstellungsverfahren dafür und verwendung davon | |
| GB202008327D0 (en) | Method for preparing 2,2'dipyridine and derivatives thereof | |
| EP3679919A4 (de) | Haut- oder haarreinigungsmittelzusammensetzung mit einem wässrigen geliermittel und verfahren zur herstellung einer wässrigen geliermittel- und reinigungsmittelzusammensetzung | |
| EP4001260A4 (de) | Dibrombenzylderivat, stereoisomer oder salz davon, verfahren zu seiner herstellung und seine verwendung | |
| EP3805271A4 (de) | Verfahren zur herstellung von sugammadex-natriumsalz | |
| AR106559A1 (es) | Suspensión acuosa para administración oral y método para su preparación | |
| SG11202107531PA (en) | Method for preparation of 1,4-sorbitan in aqueous medium | |
| EP3282006A4 (de) | Verfahren zur herstellung einer flüssigmediumzusammensetzung und herstellungsvorrichtung und kit dafür | |
| EP3530276A4 (de) | Kit zur herstellung eines mittels zur behandlung einer krankheit, mittel zur behandlung einer krankheit und verfahren zur herstellung eines mittels zur behandlung einer krankheit | |
| EP4083000A4 (de) | Verfahren zur herstellung von 1,4-cyclohexandimethanol | |
| EP3480188A4 (de) | Verfahren zur herstellung eines urat-anionenaustauscher-1-inhibitors | |
| EP3902790C0 (de) | Verbessertes verfahren zur herstellung von 4,6-dihydroxypyrimidin | |
| EP3964500A4 (de) | Salz von diaminopyrimidinverbindungen und ihre feste form, verfahren zu ihrer herstellung und ihre verwendung | |
| EP3923983A4 (de) | Chimäre rsv- und hmpv-f-proteine, immunogene zusammensetzungen und verwendungsverfahren | |
| EP3875595A4 (de) | Verfahren zur herstellung eines flüssigen mediums | |
| EP3898582A4 (de) | Neue salicylsäurederivate, pharmazeutisch unbedenkliches salz davon, zusammensetzung daraus und verfahren zur verwendung davon |